Trade War Talk Heats Up as Trump Officially Hits China With Tariffs
*By Alisha Haridasani*
Chinese officials accused the U.S. of plunging the countries with the world's two largest economies into a trade war Friday and said they'd retaliate immediately after President Donald Trump announced tariffs on Chinese exports.
The U.S. will levy a 25 percent tax on $50 billion of Chinese exports for “theft of intellectual property and technology and its other unfair trade practices,” the president said in a statement. “The United States will pursue additional tariffs if China engages in retaliatory measures.”
China, however, wasn’t deterred by the threat, promising to hit back in equal measure.
Major U.S. indices opened down on the news, with the Dow Jones tumbling nearly 300 points in early trade.
Trump decided to impose tariffs, which were initially announced in March, despite months of negotiations between the two countries. The White House has often flip flopped from tough rhetoric to declaring the trade spat [“on hold”](https://cheddar.com/videos/markets-rally-as-u-s-china-trade-war-cools). The administration even offered to save Chinese electronics company ZTE from the brink of collapse.
This round of tariffs comes on the heels of Trump’s decision to tax steel and aluminum imports coming in from the European Union, Canada, and Mexico. At the G7 summit in Canada last week, the president further antagonized U.S. allies by refusing to sign a joint statement on shared economic goals.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
